Authors' Reply to Tsivgoulis et al.: 'Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis'

Papadopoulos Dimitrios; Mitsikostas Dimos-Dimitrios D.

首页> 外文期刊>CNS drugs >Authors' Reply to Tsivgoulis et al.: 'Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis'

【24h】

Authors' Reply to Tsivgoulis et al.: 'Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis'

机译：作者回复Tsivgoulis等：“口腔疾病 - 修饰用于复发多发性硬化症的治疗：达到疾病活动或危害分析的证据的可能性”

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《CNS drugs》 |2019年第3期|共2页
作者
Papadopoulos Dimitrios; Mitsikostas Dimos-Dimitrios D.;
展开▼
作者单位

Athens Med Ctr Paleo Phaliro Clin Multiple Sclerosis Ctr Athens 17562 Greece;

Univ Athens Med Sch Aeginit Hosp Neurol Dept 1 72-74V Sophias Ave Athens 11528 Greece;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Authors' Reply to Tsivgoulis et al.: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis" [J] . Papadopoulos Dimitrios, Mitsikostas Dimos-Dimitrios D. CNS drugs . 2019,第3期

机译：作者回复Tsivgoulis等：“口腔疾病 - 修饰用于复发多发性硬化症的治疗：达到疾病活动或危害分析的证据的可能性”
2. Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis (vol 32, pg 1069, 2018) [J] . Papadopoulos Dimitrios, Mitsikostas Dimos-Dimitrios D. CNS drugs . 2019,第1期

机译：口腔疾病修饰用于复发多发性硬化的治疗方法：无疾病活动或危害分析证据的可能性（Vol 32，PG 1069,2018）
3. Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis [J] . Papadopoulos Dimitrios, Mitsikostas Dimos-Dimitrios D. CNS drugs . 2018,第11期

机译：口腔疾病改性治疗方法复发多发性硬化：达到疾病活动或危害分析的证据的可能性
4. Predicting Future Disease Activity and Treatment Responders for Multiple Sclerosis Patients Using a Bag-of-Lesions Brain Representation [C] . Andrew Doyle, Doina Precup, Douglas L. Arnold, International conference on medical imaging computing and computer-assisted intervention . 2017

机译：使用病变袋大脑表示法预测多发性硬化症患者的未来疾病活动和治疗反应者
5. Imaging Informatics-Based Electronic Patient Record and Analysis System for Multiple Sclerosis Research, Treatment, and Disease Tracking [D] . Ma, Kevin C. 2018

机译：基于信息学的电子患者记录和分析系统，用于多发性硬化研究，治疗和疾病跟踪
6. No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis [O] . Richard Nixon, Niklas Bergvall, Davorka Tomic, -1

机译：没有疾病活动的证据：口服疗法治疗复发性多发性硬化症的间接比较
7. No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis [O] . Richard Nixon, Niklas Bergvall, Davorka Tomic, 2014

机译：没有疾病活动的证据：口服疗法治疗复发性多发性硬化症的间接比较

Authors' Reply to Tsivgoulis et al.: 'Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis'

著录项

引文网络

相似文献

相关主题

期刊订阅